- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 7.00 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: N.106, I.107
- Chain H: D.89, T.94
- Chain I: N.58, F.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.11: 6 residues within 4Å:- Chain C: N.106, I.107
- Chain M: T.94
- Chain N: Y.50, N.58, F.114
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 5 residues within 4Å:- Chain E: N.106, I.107
- Chain R: T.94
- Chain S: N.58, F.114
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 6 residues within 4Å:- Chain A: R.161, C.165, N.166, T.167
- Chain B: D.73, Y.75
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.75
NAG-NAG-BMA-MAN.13: 5 residues within 4Å:- Chain C: C.165, N.166, T.167
- Chain D: D.73, Y.75
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:D.73, D:Y.75
- Hydrogen bonds: D:D.73
NAG-NAG-BMA-MAN.22: 6 residues within 4Å:- Chain E: R.161, C.165, N.166, T.167
- Chain F: D.73, Y.75
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:D.73
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.5: 4 residues within 4Å:- Chain A: N.203, T.205, S.243
- Chain J: V.78
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.168, B:S.168
NAG-NAG-BMA-MAN-MAN-MAN-MAN.14: 7 residues within 4Å:- Chain C: N.203, T.205, S.243, I.246
- Chain D: R.204, G.206
- Chain O: V.78
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.23: 7 residues within 4Å:- Chain E: N.203, T.205, S.243, I.246
- Chain F: S.168, R.204
- Chain T: P.77
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:S.168, F:S.168
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.6: 9 residues within 4Å:- Chain A: K.34, P.181, V.223, N.231, N.345, C.346, G.347, Q.407, S.414
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.347
NAG-NAG-BMA-MAN-MAN-MAN.15: 6 residues within 4Å:- Chain C: K.34, E.180, P.181, V.223, N.231, S.414
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN.24: 6 residues within 4Å:- Chain E: E.180, P.181, N.231, R.411, C.412, S.414
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.7: 6 residues within 4Å:- Chain A: Q.262, N.264, N.300, V.301, S.302, S.380
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 6 residues within 4Å:- Chain C: Q.262, N.264, N.300, V.301, S.302, S.380
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 6 residues within 4Å:- Chain E: Q.262, N.264, N.300, V.301, S.302, S.380
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.9: 13 residues within 4Å:- Chain A: T.266, H.298, N.300, D.379, T.382
- Chain H: N.45, P.60, G.61
- Chain I: R.103, I.104, G.106, V.107, V.108
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain I- Hydrogen bonds: A:R.295, I:V.107, I:V.108
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.18: 15 residues within 4Å:- Chain C: T.266, R.295, H.298, N.300, D.379, T.382
- Chain M: N.45, P.60, G.61, S.62
- Chain N: R.103, I.104, G.106, V.107, V.108
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:R.295
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.27: 13 residues within 4Å:- Chain E: T.266, H.298, N.300, D.379, T.382
- Chain R: N.45, P.60, G.61, S.62
- Chain S: R.103, I.104, G.106, V.107
No protein-ligand interaction detected (PLIP)- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.28: 6 residues within 4Å:- Chain A: N.102, R.112, G.113, K.116, R.139, K.158
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: N.121, K.130, Q.131, K.132
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain A: E.244, N.245, T.247
- Chain B: Q.167, S.168, Y.229
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: K.303, N.307, W.363
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain A: N.354, S.356
- Ligands: NAG.33, NAG.35
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: N.360
- Ligands: NAG.32, NAG.35
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: P.260, N.415
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain A: N.331, S.332, T.340, S.356
- Ligands: NAG.32, NAG.33
Ligand excluded by PLIPNAG.36: 6 residues within 4Å:- Chain C: N.102, R.112, G.113, K.116, R.139, K.158
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain C: N.121, K.130, Q.131, K.132
Ligand excluded by PLIPNAG.38: 6 residues within 4Å:- Chain C: E.244, N.245, T.247
- Chain D: S.168, G.169, Y.229
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: K.303, N.307, W.363
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.354, S.356
- Ligands: NAG.43
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.360
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: P.260, N.415
Ligand excluded by PLIPNAG.43: 6 residues within 4Å:- Chain C: N.331, S.332, T.340, N.354, S.356
- Ligands: NAG.40
Ligand excluded by PLIPNAG.44: 6 residues within 4Å:- Chain E: N.102, R.112, G.113, K.116, R.139, K.158
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain E: N.121, K.130, Q.131, K.132
Ligand excluded by PLIPNAG.46: 6 residues within 4Å:- Chain E: E.244, N.245, T.247
- Chain F: S.168, G.169, Y.229
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain E: K.303, N.307, W.363
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain E: N.354, S.356
- Ligands: NAG.49, NAG.51
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: N.360
- Ligands: NAG.48, NAG.51
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain E: P.260, Q.262, N.415
Ligand excluded by PLIPNAG.51: 7 residues within 4Å:- Chain E: N.331, S.332, T.340, N.354, S.356
- Ligands: NAG.48, NAG.49
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain G: N.94, S.96, W.97
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain G: K.116, E.117, N.120
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain A: E.1
- Chain G: N.99, R.100, N.101, L.102
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain L: N.94, S.96, W.97
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain L: E.117, N.120, Y.121
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain C: E.1
- Chain L: N.101, L.102
- Chain P: R.55
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain Q: N.94, S.96
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain Q: E.117, N.120, Y.121
Ligand excluded by PLIPNAG.60: 5 residues within 4Å:- Chain E: E.1, L.3
- Chain Q: N.99, R.100, N.101
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Torrents de la Pena, A. et al., Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization. Cell Rep (2017)
- Release Date
- 2018-04-04
- Peptides
- Envelope glycoprotein gp160: ACE
bnAb NIH45-46 scFv: BDF
Envelope glycoprotein gp160: GLQ
bnAb PGT122 Fab light chain: HMR
bnAb PGT122 Fab heavy chain: INS
bnAb 35O22 Fab heavy chain: JOT
bnAb 35O22 Fab light chain: KPU - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
FE
QB
DD
OF
WG
AL
JQ
RH
BM
KR
SI
CN
LS
TJ
HO
MT
UK
IP
NU
V
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 7.00 Å
- Oligo State
- hetero-3-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Torrents de la Pena, A. et al., Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization. Cell Rep (2017)
- Release Date
- 2018-04-04
- Peptides
- Envelope glycoprotein gp160: ACE
bnAb NIH45-46 scFv: BDF
Envelope glycoprotein gp160: GLQ
bnAb PGT122 Fab light chain: HMR
bnAb PGT122 Fab heavy chain: INS
bnAb 35O22 Fab heavy chain: JOT
bnAb 35O22 Fab light chain: KPU - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
FE
QB
DD
OF
WG
AL
JQ
RH
BM
KR
SI
CN
LS
TJ
HO
MT
UK
IP
NU
V